1-4 of 4
Paolo Mascagni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ITF2357, a Novel Histone-Deacetylase Inhibitor, Is Effective against Peripheral T-Cell Lymphomas in Vivo

Pier Paolo Piccaluga, Maura Rossi, Aurora Esposito, Pier Luigi Tazzari, Francesca Ricci, Giordano Nicoletti, Lorena Landuzzi, Stefano Fanti, Valentina Ambrosini, Flavio Leoni, Paolo Mascagni, Anna Gazzola, Pier Luigi Lollini, Pier Luigi Zinzani, Stefano A. Pileri
Journal: Blood
Blood (2008) 112 (11): 4981.
https://doi.org/10.1182/blood.V112.11.4981.4981
Published: 2008
Journal Articles

Histone deacetylase inhibitors prevent exocytosis of interleukin-1β-containing secretory lysosomes: role of microtubules

Sonia Carta, Sara Tassi, Claudia Semino, Gianluca Fossati, Paolo Mascagni, Charles A. Dinarello, Anna Rubartelli
Journal: Blood
Blood (2006) 108 (5): 1618–1626.
https://doi.org/10.1182/blood-2006-03-014126
Published: 2006
Journal Articles

Potent Cytotoxicity Against Multiple Myeloma and Acute Myeloid Leukemia Cells by a New Histone Deacetylase Inhibitor ITF2357.

Alessandro Rambaldi, MD, Caterina Micò, Lucia Cuppini, Marcello Domenghini, Gian Maria Borleri, Anna Maria Barbui, MD, Flavio Leoni, Paolo Mascagni, MD, Anna Salvi, Josee Golay, PhD, Martino Introna, MD
Journal: Blood
Blood (2005) 106 (11): 3361.
https://doi.org/10.1182/blood.V106.11.3361.3361
Published: 2005
Journal Articles

Downregulation of Graft-Versus-Host-Disease (GVHD) by Treatment with Histone Deacetylase (HDAC) Inhibitors Involves Modulation of the JAK/STAT Signaling Pathway.

Corinna Leng, MD, Margathe Gries, Suzanne Lentzsch, MD, Simone Lusatis, Paolo Mascagni, PHD, Markus Y. Mapara, MD
Journal: Blood
Blood (2004) 104 (11): 3050.
https://doi.org/10.1182/blood.V104.11.3050.3050
Published: 2004